Sector: health
Conviction from: NASDAQCitrini
52-week range: 100.99188.73
Bioprocessing products for biologic-drug manufacturing
5 tracked filer(s) hold this · 3 opened, 0 added, 1 trimmed in 30-JUN-2026
Aggregate 13FScore 65 — mean of 5 scored holder(s) · buyers (new/add) avg 70. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Stanley Druckenmiller / Duquesne | 95 | New buy | 77,400 | $10,560 | 0.2% |
| Louis Bacon / Moore | 53 | New buy | 37,549 | $5,123,186 | 0.1% |
| Paul Tudor Jones / Tudor | 63 | New buy | 25,678 | $3,503,506 | 0.0% |
| Ancora | 40 | Holds (flat) | 12 | $1,637 | 0.0% |
| Steve Cohen / Point72 | 76 | Trimmed -71% | 166,157 | $22,670,461 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #124 — State of the Themes: June 2026 | 2026-06-01 | LONG |
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | LONG |